{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:28:36Z","timestamp":1793986116909,"version":"4.8.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T00:00:00Z","timestamp":1519171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/s41372-018-0074-2","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T19:49:10Z","timestamp":1519242550000},"page":"456-461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Infant size and the association between maternal circulating angiogenic factors and preeclampsia"],"prefix":"10.1038","volume":"38","author":[{"given":"Michael C.","family":"Honigberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen W.","family":"Seely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee-Hak","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"McElrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,21]]},"reference":[{"key":"74_CR1","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Obstet Gynecol. 2013;122:1122\u201331.","DOI":"10.1097\/01.AOG.0000437382.03963.88"},{"key":"74_CR2","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard SE, Min JY, Merchan J, Lim KH, Li J, Libermann TA, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649\u201358.","journal-title":"J Clin Invest"},{"key":"74_CR3","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672\u201383.","journal-title":"N Engl J Med"},{"key":"74_CR4","first-page":"1266","volume":"101","author":"BM Polliotti","year":"2003","unstructured":"Polliotti BM, Fry AG, Saller DN, Mooney RA, Cox C, Miller RK. Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet Gynecol. 2003;101:1266\u201374.","journal-title":"Obstet Gynecol"},{"key":"74_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ajog.2007.05.022","volume":"197","author":"ER Unal","year":"2007","unstructured":"Unal ER, Robinson CJ, Johnson DD, Chang EY. Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia. Am J Obstet Gynecol. 2007;197:211.e1\u2013e4.","journal-title":"Am J Obstet Gynecol"},{"key":"74_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1471-2393-13-110","volume":"3","author":"PM Villa","year":"2013","unstructured":"Villa PM, Hamalainen E, Maki A, R\u00e4ikk\u00f6nen K, Pesonen AK, Taipale P, et al. Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort. BMC Pregnancy Childbirth. 2013;3:110.","journal-title":"BMC Pregnancy Childbirth"},{"key":"74_CR7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ajog.2011.07.037","volume":"206","author":"S Verlohren","year":"2012","unstructured":"Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, et al. The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol. 2012;206:e1\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"74_CR8","doi-asserted-by":"publisher","first-page":"S9.e1","DOI":"10.1016\/j.ajog.2015.08.003","volume":"213","author":"CW Redman","year":"2015","unstructured":"Redman CW, Staff AC. Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. Am J Obstet Gynecol. 2015;213:S9.e1\u2013S9.e4.","journal-title":"Am J Obstet Gynecol"},{"key":"74_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","volume":"374","author":"HZ Zeisler","year":"2016","unstructured":"Zeisler HZ, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstrom M, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374:13\u201322.","journal-title":"N Engl J Med"},{"key":"74_CR10","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.3109\/14767058.2012.713055","volume":"25","author":"AG Moore","year":"2012","unstructured":"Moore AG, Young H, Keller JM, Ojo LR, Yan J, Simas TA, et al. Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia. J Matern Fetal Neonatal Med. 2012;25:2651\u201357.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"74_CR11","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","volume":"125","author":"S Rana","year":"2012","unstructured":"Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 2012;125:911\u201319.","journal-title":"Circulation"},{"key":"74_CR12","doi-asserted-by":"publisher","first-page":"407.e1","DOI":"10.1016\/j.ajog.2012.08.010","volume":"207","author":"TF McElrath","year":"2012","unstructured":"McElrath TF, Lim KH, Pare E, Rich-Edwards J, Pucci D, Troisi R, et al. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy. Am J Obstet Gynecol. 2012;207:407.e1\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"74_CR13","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/jog.13340","volume":"43","author":"I Furuta","year":"2017","unstructured":"Furuta I, Umazume T, Kojima T, Chiba K, Nakagawa K, Hosokawa A, et al. Serum placental growth factor and soluble fms-like tyrosine kinase 1 at mid-gestation in healthy women: Association with small-for-gestational age neonates. J Obstet Gynaecol Res. 2017;43:1152\u201358.","journal-title":"J Obstet Gynaecol Res"},{"key":"74_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/AOG.0000000000000367","volume":"124","author":"I Herraiz","year":"2014","unstructured":"Herraiz I, Droge LA, Gomez-Montes E, Henirch W, Galindo A, Verlohren S. Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction. Obstet Gynecol. 2014;124:265\u201373.","journal-title":"Obstet Gynecol"},{"key":"74_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/jp.2015.170","volume":"36","author":"MC Honigberg","year":"2016","unstructured":"Honigberg MC, Cantonwine DE, Thomas AM, Lim KH, Parry SI, McElrath TF. Analysis of changes in maternal circulating angiogenic factors throughout pregnancy for the prediction of preeclampsia. J Perinatol. 2016;36:172\u201377.","journal-title":"J Perinatol"},{"key":"74_CR16","unstructured":"PlGF-based testing to help diagnosed suspected preeclampsia. May 2016. Available at: \n                    https:\/\/www.nice.org.uk\/guidance\/dg23\/chapter\/1-Recommendations\n                    \n                  . [Accessed 20 April 2017]."},{"key":"74_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejogrb.2016.08.036","volume":"206","author":"D Martino Di","year":"2016","unstructured":"Di Martino D, Cetin I, Frusca T, Ferrazzi E, Fuse F, Gervasi MT, et al. Italian Advisory Board: sFlt-1\/PlGF ratio and preeclampsia, state of the art and developments in diagnostic, therapeutic, and clinical management. Eur J Obstet Gynecol Reprod Biol. 2016;206:70\u20133.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"74_CR18","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3109\/14767058.2015.1048431","volume":"29","author":"T Chaiworapongsa","year":"2016","unstructured":"Chaiworapongsa T, Romero R, Whitten AE, Korzeniewski SJ, Chaemsaithong P, Hernandez-Andrade E, et al. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require preterm delivery and mothers who will develop preeclampsia. J Matern Fetal Neonatal Med. 2016;29:1214\u201328.","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41372-018-0074-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-018-0074-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-018-0074-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:26:16Z","timestamp":1684617976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-018-0074-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,21]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["74"],"URL":"https:\/\/doi.org\/10.1038\/s41372-018-0074-2","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,21]]},"assertion":[{"value":"16 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}